Annette Marcantonio
About Annette Marcantonio
Annette Marcantonio Vice President, Clinical Operations
Annette Marcantonio serves as the Vice President of Clinical Operations at Jasper Therapeutics. She brings over 30 years of experience in senior clinical operations and development roles to the company. Her extensive background spans various leadership positions, making her a valuable asset to Jasper Therapeutics' clinical strategies and operations.
Annette Marcantonio Education and Background
Annette Marcantonio completed her Bachelor's degree at Loyola-Marymount University and later earned an MBA from the University of Phoenix. Her educational background laid the foundation for a robust career in clinical operations and development, where she has held several key leadership roles across different biopharmaceutical companies.
Annette Marcantonio Role at Neurogastrx
At Neurogastrx, Annette Marcantonio held the position of Vice-President of Clinical Affairs. During her tenure, she successfully led the advancement of the NG101 program in Gastroparesis. Her contributions were pivotal in moving the program forward, showcasing her adeptness in clinical affairs and program management.
Annette Marcantonio and Aimmune Palforzia™ Approval
Annette Marcantonio served as Vice-President of Clinical Operations at Aimmune. She was instrumental in designing and implementing the clinical development program for Palforzia™, the first-in-class peanut allergy treatment. Her leadership played a crucial role in the studies and efforts that led to the drug's approval.
Annette Marcantonio Expertise in Marketing Applications
Annette Marcantonio has been a key participant in submitting several US and EU marketing applications. Her expertise has directly contributed to successful product approvals and label expansions for multiple drugs and biologics. Additionally, she has provided consulting support to various biopharmaceutical companies, including serving as a regulatory representative to the FDA for one client.